In April Linda Oskam visited Pakistan on two back-to-back
missions:

1. To finalize the National Laboratory Strategic
Plan

2. To start the involvement of the Fleming Fund in fighting
antimicrobial resistance (AMR)

Finalization of the
National Laboratory Strategic Plan

In December 2017 the National Laboratory Policy was endorsed
by the Pakistan Federal government. We facilitated the development of this
policy by the National Laboratory Working Group under the leadership of the
National Institute of Health and supported by WHO. During 3 workshops in
October 2017, January and April 2018 the logical next step, namely a Strategic
Plan was developed and is now ready for submission to the government.

Fighting AMR

The UK Government has set up the Fleming Fund to tackle the
growing problem of drug-resistant infection. As part of its activities, the
Fleming Fund will support countries to set up a sturdy, sustainable, One Health
based AMR surveillance system that generates reliable data that can be reported
into the Global Antimicrobial Resistance Surveillance System (GLASS)

From 11 to 20 April, Linda Oskam was part of the team that
carried out the initial scoping mission to get a better idea of current AMR
surveillance capacity in Pakistan. During meetings with numerous stakeholders
and technical partners, it became clear that Pakistan faces enormous challenges
in the field of AMR, but also that there is the will to take up this challenge.